Back

Differences in outcomes between percutaneous coronary intervention of bystander coronary lesions and medical therapy in patients undergoing transcatheter aortic valve implantation

13 May 2024 (12:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Interventional cardiology Aortic Valve Intervention HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ricardo Carvalheiro

University Hospital Lisboa Central, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Left ventricular cardiac recovery and reverse remodeling in patients with aortic stenosis after TAVI: a systematic review and meta-analysis
Doctor E. Hasabo (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Screening for amyloidosis in patients scheduled for aortic valve replacement
Doctor I. Mattig (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Factors associated with heart failure events in patients with new-onset persistent left bundle branch block at discharge after transcatheter aortic valve replacement
Doctor N. Vaxelaire (Nancy, FR)
Abstract Slides Video
Presentation thumbnail
Valve-in-valve transcatheter aortic valve implantation in patients with failed bioprosthetic aortic valves: an analysis of safety, feasibility and clinical outcomes.
Doctor B. Lacerda Teixeira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Transcatheter aortic valve replacement in bicuspid aortic valve patients
Doctor F. Nascimento Ferreira (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Interventional cardiology

The Event

Event poster

Heart Failure 2024

13 May 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Outcomes of percutaneous coronary interventions after transcatheter aortic valve replacement
thumbnail
Congress Presentation
Percutaneous coronary revascularization timing in patients undergoing transcatheter aortic valve implantation
thumbnail
Congress Presentation
Indication for revascularisation in patients undergoing aortic valve replacement

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources